A CAS number can prevent a costly and potentially dangerous mix-up. Pseudoephedrine CAS 90-82-4 identifies pseudoephedrine in its free-base form, not every salt, product format, or medication package carrying the word pseudoephedrine. For buyers, handlers, and anyone reviewing chemical documentation, that distinction affects identity checks, storage decisions, legal compliance, and safety.
Pseudoephedrine is a sympathomimetic compound commonly associated with short-term nasal decongestion. It can increase nervous-system activity and may raise heart rate or blood pressure. Treat it as an active drug substance, not an ordinary consumer chemical. A label, a claimed purity percentage, or a familiar name is never a substitute for verified documentation and appropriate medical or professional guidance.
What Pseudoephedrine CAS 90-82-4 Identifies
CAS Registry Numbers are identifiers assigned to specific chemical substances. The number 90-82-4 is associated with pseudoephedrine free base. That matters because pseudoephedrine may also appear as a salt in regulated pharmaceutical products. A different form can have a different molecular weight, physical behavior, labeling requirement, and regulatory treatment.
Do not assume that two records describe the same material merely because both say “pseudoephedrine.” Confirm the full chemical name, CAS number, salt or free-base designation, batch reference, stated assay method, and safety documentation. If a seller cannot clearly identify what form is being offered, that is a reason to stop and verify before handling anything.
Pseudoephedrine should also not be confused with ephedrine. They are related compounds with different stereochemical identities and different regulatory, pharmacological, and product considerations. Small wording differences on a label can represent a meaningful difference in the material being described.
Why form and documentation matter
The free base may be described differently from pseudoephedrine hydrochloride or another finished pharmaceutical form. Product names alone are not enough for comparison. A responsible review should look for a consistent chain of information across the container label, batch documentation, certificate of analysis, and safety data sheet.
Documentation can support identity review, but it does not guarantee appropriate use or establish that a material is suitable for personal consumption. It also does not replace the controls required for regulated medicines or chemicals. Claims such as “pharmaceutical grade” should be backed by traceable records, not treated as proof on their own.
Health Risks and Medication Interactions
Pseudoephedrine can cause effects beyond relief of congestion. Common adverse effects may include nervousness, restlessness, difficulty sleeping, headache, dry mouth, nausea, tremor, and a fast or forceful heartbeat. Effects vary with the individual, other medicines, underlying conditions, and the product formulation.
The risk profile becomes more serious for people with uncontrolled high blood pressure, heart disease, certain thyroid conditions, diabetes, glaucoma, urinary retention, or a history of stimulant sensitivity. Older adults and people taking multiple medications may be more vulnerable to adverse effects. Pregnancy, breastfeeding, and use in children require advice from a qualified clinician or pharmacist rather than guesswork.
Interactions deserve particular caution. Combining pseudoephedrine with monoamine oxidase inhibitors can create dangerous blood-pressure effects. Other stimulants, some ADHD medicines, large amounts of caffeine, certain antidepressants, and some cold-and-flu products can also increase unwanted cardiovascular or nervous-system effects. Many combination products contain more than one active ingredient, so duplicate exposure is a real concern.
A person who develops chest pain, severe headache, fainting, shortness of breath, confusion, seizure activity, or signs of a severe allergic reaction needs urgent medical assessment. Suspected overdose should be treated as an emergency. Do not wait for symptoms to “wear off,” and do not attempt to manage a serious reaction with additional substances.
Handling and Storage Expectations
Bulk chemical handling introduces risks that are separate from ordinary medication use. Fine powders can become airborne during transfer, creating a greater chance of accidental exposure to the eyes, skin, or respiratory tract. Handling should be limited to people who understand the material, use suitable protective equipment, and follow the applicable safety documentation.
Keep containers tightly closed, correctly labeled, and protected from moisture, heat, direct light, and unauthorized access. Avoid storing pseudoephedrine near food, drink, household medications, or materials that could be confused with it. A secure, dry storage area with clear inventory controls is the practical standard, especially where multiple chemicals or formulations are present.
Never rely on appearance, odor, or texture to identify a powder. Visual inspection cannot confirm purity, identity, contamination, or potency. If a container is damaged, mislabeled, leaking, or missing its batch information, isolate it and seek qualified guidance on safe handling and disposal under local requirements.
Purity claims require context
Purity is often presented as a simple percentage, but an assay result does not answer every quality question. It may not reveal all impurities, residual solvents, moisture content, packaging failures, or whether the sample and the shipped batch are truly matched. Analytical methods, sampling procedures, dates, and independent traceability all affect how much confidence a buyer can reasonably place in a claim.
For regulated drug substances, quality is not just about a high number on a label. It is about verified identity, controlled manufacturing, appropriate packaging, traceable lots, and compliance with the laws that govern the intended use. If any part of that chain is unclear, caution is the right response.
US Legal Controls Around Pseudoephedrine
In the United States, pseudoephedrine is subject to purchase, recordkeeping, and distribution controls because it can be diverted for illegal drug manufacturing. Federal and state rules may limit retail quantities, require identification, restrict sales locations, and impose additional obligations on businesses that handle or distribute it.
Those controls are not optional details to work around. They exist because unregulated access, diversion, and improper bulk handling carry public-health and legal consequences. Rules can differ by state and can change over time, particularly for online transactions, interstate shipments, and large-quantity orders.
Anyone dealing with a pseudoephedrine-containing product should confirm the current legal requirements that apply to their location, role, and intended use. A private sale, an overseas shipment, a wholesale inquiry, or a claim of discreet delivery does not remove the obligation to comply with applicable law. When the status of a transaction is uncertain, pause rather than assume.
A Sensible Standard for Verification
The most useful question is not simply whether a material is labeled pseudoephedrine. Ask whether the identity, form, documentation, handling conditions, and legal path are all clear. If the answer is incomplete, the risk is not limited to wasted money. Misidentification can lead to unsafe exposure, medication errors, regulatory problems, or delayed treatment during an adverse event.
For legitimate medical use, use only products obtained through lawful, regulated channels and follow the directions of a clinician or pharmacist. For professional or industrial settings, maintain clear records, secure storage, and procedures that prevent diversion and accidental exposure. Careful verification before a container is opened is far safer than trying to correct an uncertainty afterward.

